by Peeyush Shrivastava
(Mason, OH, USA)

Genetesis is seeking $1.2M from strategic investors.

To learn more, please check our website at, email us at to get in touch with an executive or watch this medical animation process of our work:

Genetesis LLC is a biotechnology and bioinformatics driven company oriented towards personalizing diagnosis and treatment of membrane excitability disorders through the use of novel algorithms which analyze, in real-time, the complete human electrophysiology. Using our proprietary, patent-pending system and methodology, Genetesis quantifies the entire human electrophysiology, and compares data to a massive clinical database of ion channel activities and their corresponding conditions. The company provides a simplistic and concise output of these quantifications to aid physicians in creating a holistic, personalized diagnosis.

Peeyush Shrivastava, Founder and CEO of Genetesis is an Intel STS Semifinalist, GE STAR Awardee, and was recently named a Thiel Fellowship Finalist for his work with the cutting edge biotech startup, which represents a never before seen, yet highly desired and well received diagnostics platform and end to end solution. This is the next medical breakthrough - we know it as the creators, and the market knows it as per the explicit desires from our end users.

Click here to post comments

Join in and write your own page! It's easy to do. How? Simply click here to return to Health Care-Medical-Biotech Investments.

Check out these curated articles on on Funding related topics:

To join our Facebook page, and get regular updates through Facebook, click our little logo on the right, you'll get on our Facebook page, and there you can click on the 'Like' button